






| From Publication: | Riffle <i>et al</i>. (2010) (Unpublished Data) |
| Notes: | Complex predicted from the combined set of Gavin (2002), Gavin (2006), Ho (2002) and Krogan (2006); at p-value cutoff of 1E-7 |
| Complex Size: | 4 proteins |
Given the number of proteins in the complex (A), total proteins annotated with a given GO term (B), and the total number of annotated proteins (T); the p-value represents the chances of randomly having the number of proteins in the complex annotated with a specific GO term (I).
Only showing terms with a p-value less than or equal to 0.01.
| GO Term |
P-value |
A |
B |
I |
T |
| nucleoplasm part | 2.2451E-6 | 4 | 245 | 4 | 6292 |
| nucleoplasm | 3.0322E-6 | 4 | 264 | 4 | 6292 |
| nuclear lumen | 2.6539E-5 | 4 | 453 | 4 | 6292 |
| SLIK (SAGA-like) complex | 3.6271E-5 | 4 | 16 | 2 | 6292 |
| mediator complex | 4.6226E-5 | 4 | 18 | 2 | 6292 |
| SAGA complex | 6.9734E-5 | 4 | 22 | 2 | 6292 |
| SAGA-type complex | 7.6359E-5 | 4 | 23 | 2 | 6292 |
| organelle lumen | 1.2008E-4 | 4 | 660 | 4 | 6292 |
| intracellular organelle lumen | 1.2008E-4 | 4 | 660 | 4 | 6292 |
| membrane-enclosed lumen | 1.5203E-4 | 4 | 700 | 4 | 6292 |
| histone acetyltransferase complex | 2.8424E-4 | 4 | 44 | 2 | 6292 |
| nuclear part | 9.4015E-4 | 4 | 1103 | 4 | 6292 |
| protein complex | 1.0617E-3 | 4 | 1137 | 4 | 6292 |
| Ada2/Gcn5/Ada3 transcription activator complex | 3.1756E-3 | 4 | 5 | 1 | 6292 |
| macromolecular complex | 4.5471E-3 | 4 | 1635 | 4 | 6292 |
| transcription factor TFIID complex | 9.5041E-3 | 4 | 15 | 1 | 6292 |
Given the number of proteins in the complex (A), total proteins annotated with a given GO term (B), and the total number of annotated proteins (T); the p-value represents the chances of randomly having the number of proteins in the complex annotated with a specific GO term (I).
Only showing terms with a p-value less than or equal to 0.01.
| GO Term |
P-value |
A |
B |
I |
T |
| histone acetylation | 1.8962E-4 | 4 | 36 | 2 | 6292 |
| protein amino acid acetylation | 3.1085E-4 | 4 | 46 | 2 | 6292 |
| protein amino acid acylation | 5.1246E-4 | 4 | 59 | 2 | 6292 |
| transcription from RNA polymerase II promoter | 5.749E-4 | 4 | 335 | 3 | 6292 |
| covalent chromatin modification | 1.1395E-3 | 4 | 88 | 2 | 6292 |
| histone modification | 1.1395E-3 | 4 | 88 | 2 | 6292 |
| transcription, DNA-dependent | 1.9112E-3 | 4 | 503 | 3 | 6292 |
| RNA biosynthetic process | 1.9676E-3 | 4 | 508 | 3 | 6292 |
| transcription | 2.5116E-3 | 4 | 552 | 3 | 6292 |
| chromosome organization | 2.5518E-3 | 4 | 555 | 3 | 6292 |
| chromatin modification | 4.1046E-3 | 4 | 168 | 2 | 6292 |
| chromatin organization | 5.954E-3 | 4 | 203 | 2 | 6292 |
| regulation of transcription involved in G1 phase of mitotic cell cycle | 8.8726E-3 | 4 | 14 | 1 | 6292 |
Given the number of proteins in the complex (A), total proteins annotated with a given GO term (B), and the total number of annotated proteins (T); the p-value represents the chances of randomly having the number of proteins in the complex annotated with a specific GO term (I).
Only showing terms with a p-value less than or equal to 0.01.
| GO Term |
P-value |
A |
B |
I |
T |
| general RNA polymerase II transcription factor activity | 3.987E-6 | 4 | 64 | 3 | 6292 |
| transcription regulator activity | 8.286E-6 | 4 | 339 | 4 | 6292 |
| RNA polymerase II transcription factor activity | 3.3964E-5 | 4 | 130 | 3 | 6292 |
| RNA polymerase II transcription mediator activity | 6.9734E-5 | 4 | 22 | 2 | 6292 |